|Articles|April 1, 2003

Taking HIV to HAART Hasn't Solved Zoster

Boston - Herpes zoster infection rates in individuals living with HIV-1 infection have not improved since the availability of highly active antiretroviral therapy (HAART), according to research presented here at the Conference on Retroviruses and Opportunistic Infections.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


Latest CME